Savient Names Clement CEO
This article was originally published in The Pink Sheet Daily
Savient Pharmaceuticals has tapped President & Chief Operating Officer Christopher Clement as CEO following the retirement of Sim Fass.
You may also be interested in...
The firm will restate first quarter and 2004 year-end results due to less-than-expected returns of the anabolic agent.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.